Key statistics
As of last trade Xenon Pharmaceuticals Inc (XENE:NMQ) traded at 41.97, -10.68% below its 52-week high of 46.99, set on Feb 27, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 41.55 |
|---|---|
| High | 42.53 |
| Low | 41.32 |
| Bid | 41.74 |
| Offer | 42.20 |
| Previous close | 42.55 |
| Average volume | 919.70k |
|---|---|
| Shares outstanding | 83.19m |
| Free float | 76.81m |
| P/E (TTM) | -- |
| Market cap | 3.54bn USD |
| EPS (TTM) | -4.36 USD |
Data delayed at least 15 minutes, as of Mar 03 2026 15:25 GMT.
More ▼
- Xenon Reports Q4 and Full Year 2025 Financial Results and Provides Business Update
- Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Xenon Outlines Key Upcoming Milestones at the 2026 J.P. Morgan Healthcare Conference
- Xenon to Present at the 44th Annual J.P. Morgan Healthcare Conference
- Xenon Showcases New 48-Month Azetukalner OLE Study Data in Epilepsy at AES 2025
- Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Xenon Announces Investor Webinar Highlighting Azetukalner and Epilepsy Data from AES 2025
- Xenon to Present New Azetukalner OLE Study Data in Epilepsy at AES 2025
- Xenon to Present at Upcoming Investor Conferences
- Xenon Reports Third Quarter 2025 Financial Results & Business Update
More ▼
